Schrödinger, Inc. Reports Second Quarter 2020 Financial Results and Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- Harry and Meghan surprised by King Charles' letter on their status
- Wall St slips as steep oil prices stoke inflation concerns ahead of CPI
- Qualcomm to issue warrant to Amazon for up to 25M shares
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Schrodinger Inc. (SDGR) Tops Q2 EPS by 23c, Revenues Beat
August 10, 2020 6:07 AM EDTSchrodinger Inc. (NASDAQ: SDGR) reported Q2 EPS of ($0.05), $0.23 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $23.09 million versus the consensus estimate of $17.93 million.
Total revenue of $23.1 million, up 21% year-over-yearSoftware revenue of $20.9 million, up 44% year-over-yearNew strategic agreements with Thermo Fisher and Viva Biotech Rapid progress across internal pipeline; three programs in late-stage discoveryWe made excellent progress during the second quarter across our entire business, including growing our software business, advancing our drug discovery programs, and developing new platform capabilities, said... More
